India's AI Dialysis Ecosystem Signals New Era in Kidney Care Systems

India’s healthcare sector has entered a new phase of innovation with the launch of the country’s first AI-powered dialysis ecosystem in Ahmedabad, marking a major step toward smarter and more connected kidney care systems.

The newly introduced technology combines artificial intelligence in healthcare, cloud-based monitoring, and locally developed dialysis equipment to improve treatment quality, patient monitoring, and operational efficiency in dialysis care. The development highlights how AI is gradually transforming chronic kidney disease treatment in India’s medical sector.

The ecosystem has been developed by Lord's Mark Industries and centres around the Renalyx Machine, an indigenously designed smart hemodialysis system. Unlike traditional dialysis machines that operate independently, the Renalyx platform is integrated with AI-driven clinical tools capable of analysing treatment data in real time.

The system can monitor patient conditions continuously, generate alerts for potential complications, and support doctors in making quicker and more accurate clinical decisions.

Also Read: Why Are Heart Failure and CKD Patients Facing Hidden Risks?

A major innovation within the platform is RenalOS, an AI-enabled monitoring system that allows healthcare professionals to supervise dialysis sessions remotely. Through cloud connectivity and centralised patient data management, doctors and technicians can track treatment progress beyond hospital visits, enabling a more continuous and personalised approach to digital healthcare innovation.

Experts believe the innovation is significant because it goes beyond introducing a new dialysis machine. Instead, it creates a complete digital ecosystem that combines AI, remote monitoring, and treatment management within a single framework. This integrated model could help reduce operational errors, improve patient safety, and allow hospitals to expand dialysis services more efficiently.

The ecosystem also includes a Dialysis-as-a-Service model known as Aureoon. This initiative aims to help hospitals and healthcare providers establish dialysis centres without major upfront investments in infrastructure and equipment. The approach could improve access to advanced dialysis treatment in smaller cities and underserved regions where specialised kidney care facilities remain limited.

The launch reflects the growing role of AI in medical technology in India’s healthcare industry, where companies are increasingly investing in predictive analytics, automation, and connected medical technologies. For patients with chronic kidney disease, who often undergo dialysis several times a week, remote patient monitoring and personalised treatment support could improve long-term care and overall quality of life.

The initiative also supports the government’s “Make in India” vision by showcasing India’s capability to manufacture advanced medical devices in India domestically. The company plans to establish 50 AI-enabled dialysis centres across India by March 2027 and is also working toward international regulatory approvals, including certification from the US FDA, as part of its global expansion strategy.